Back to results
CompletedPhase 2

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

NCT00119262

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Eastern Cooperative Oncology Group

Boston, Massachusetts, United States

View on ClinicalTrials.gov
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer — TrialFind